28-30 However, an unblinded randomized controlled trial (RCT) comparing the efficacy of metformin (500 mg 3 times daily) with rosiglitazone (4 mg/d), another T2DM medication, on AN neck lesions in patients who were overweight and obese found no significant effects in lesion severity and only modest improvements in skin texture in both groups at 12 weeks following treatment initiation
This is a compounded product and has not been approved by the FDA
A targeted infusion supports the body's ability to replenish what daily demands take away
Slow dose escalation is the primary tool for managing GI discomfort
Nichols S, McGregor G, Al-Mohammad A, Ali AN, Tew G, ODoherty AF
How can clinicians and researchers stay up to date on the most clinically relevant trials